Lab-on-a-Chip Market Players:
- Agilent Technologies Inc.
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Becton, Dickinson and Company
- Danaher Corporation
- Bio-Rad Laboratories
- Abbott Laboratories
- Hoffmann-La Roche AG
- PerkinElmer Inc.
- IDEX Corporation
- Thermo Fisher Scientific Inc.
- Cepheid Inc.
- Biacore AB
Key companies in the lab-on-a-chip market are driving innovation through strategic partnerships, advanced technologies, and product development. Companies are introducing cutting-edge solutions, such as AI-powered diagnostic tools, precision systems for drug development, and advanced testing devices for medical imaging. In October 2019, BASF and Biomillenia collaborate using microbiome-on-a-chip-technology to discover dermocosmetic ingredients, enhancing skin health by modulating and maintaining diverse skin microbiota. Their focus on miniaturization, automation, and cost-effectiveness is enhancing lab-on-a-chip applications, revolutionizing healthcare, diagnostics, and research capabilities.
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In the year 2026, the industry size of lab-on-a-chip is assessed at USD 8.19 billion.
The global lab-on-a-chip market size was valued at more than USD 7.54 billion in 2025 and is expected to register a CAGR of over 9.6%, exceeding USD 18.86 billion revenue by 2035.
North America lab-on-a-chip market will hold around 50% share by 2035, driven by chronic disease prevalence and government investments in diagnostic R&D.
Key players in the market include Agilent Technologies Inc., Becton, Dickinson and Company, Danaher Corporation, Bio-Rad Laboratories, Abbott Laboratories, Hoffmann-La Roche AG, PerkinElmer Inc., IDEX Corporation, Thermo Fisher Scientific Inc., Cepheid Inc., Biacore AB, BASF, Biomillenia, Syensgo, Emulseo, Microchip Technology.
